Literature DB >> 7939737

[Development of arthrosis after rupture of the anterior cruciate ligament. A comparison of surgical and conservative therapy].

C Fink1, C Hoser, K P Benedetto.   

Abstract

Degenerative changes of the knee joint are a well-known problem after ACL injury. In this study two groups of patients, one treated with ACL reconstruction (OP group) and one with conservative treatment (non OP group), were compared with reference to the development of arthritic signs after a mean follow-up of 77.9 (+/- 7.5). X-rays, taken at the time of the diagnosis of the ACL rupture and at follow up, were rated according to the classification described by Fairbank: 20% of the patients in the OP group and 50% in the non OP group showed no degenerative changes. The number of severe changes (grade III) was higher in the non OP group (18%) than in the OP group (4.5%). For patients in the non OP group a significant correlation was found between sports activity and the development of osteoarthritis. Meniscus pathology was seen to be a factor promoting the development of degenerative changes, but a significant correlation could not be found for either group.

Entities:  

Mesh:

Year:  1994        PMID: 7939737

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  11 in total

1.  A prospective study to assess the outcomes of revision anterior cruciate ligament reconstruction.

Authors:  Samer Samir Sayed Mahmoud; Saurabh Odak; Stephen Coogan; Michael J McNicholas
Journal:  Int Orthop       Date:  2014-04-01       Impact factor: 3.075

Review 2.  WITHDRAWN: Surgical versus conservative interventions for anterior cruciate ligament ruptures in adults.

Authors:  Eric Linko; Arsi Harilainen; Antti Malmivaara; Seppo Seitsalo
Journal:  Cochrane Database Syst Rev       Date:  2016-04-14

3.  Non-operative treatment of ACL injury is associated with opposing subjective and objective outcomes over 20 years of follow-up.

Authors:  Peter Gföller; Elisabeth Abermann; Armin Runer; Christian Hoser; Mario Pflüglmayer; Guido Wierer; Christian Fink
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-11-22       Impact factor: 4.342

Review 4.  [Progression of arthrosis after alloplasty--what factors play a role?].

Authors:  K Küllmer; R Letsch; K P Schmit-Neuerburg; B Turowski
Journal:  Unfallchirurgie       Date:  1996-06

Review 5.  Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis.

Authors:  Mazda Farshad; Christian Gerber; Dominik C Meyer; Alexander Schwab; Patricia R Blank; Thomas Szucs
Journal:  BMC Health Serv Res       Date:  2011-11-19       Impact factor: 2.655

6.  Ligament Injury, Reconstruction and Osteoarthritis.

Authors:  Braden C Fleming; Michael J Hulstyn; Heidi L Oksendahl; Paul D Fadale
Journal:  Curr Opin Orthop       Date:  2005-10

7.  Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis.

Authors:  Shaowei Wang; Xiaochun Wei; Jingming Zhou; Jing Zhang; Kai Li; Qian Chen; Richard Terek; Braden C Fleming; Mary B Goldring; Michael G Ehrlich; Ge Zhang; Lei Wei
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

8.  Studies of polyurethane urea bands for ACL reconstruction.

Authors:  Elisabeth Liljensten; Katrin Gisselfält; Bengt Edberg; Hans Bertilsson; Per Flodin; Anders Nilsson; Anders Lindahl; Lars Peterson
Journal:  J Mater Sci Mater Med       Date:  2002-04       Impact factor: 3.896

Review 9.  [Complications after cruciate ligament reconstruction].

Authors:  H O Mayr; C Zeiler
Journal:  Orthopade       Date:  2008-11       Impact factor: 1.087

10.  Effects of ACL interference screws on articular cartilage volume and thickness measurements with 1.5 T and 3 T MRI.

Authors:  M E Bowers; G A Tung; N Trinh; E Leventhal; J J Crisco; B Kimia; B C Fleming
Journal:  Osteoarthritis Cartilage       Date:  2007-10-22       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.